April 16, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Conexiant

April 08, 2026

Fighting sugar, protecting patients: ADA advocacy in action 

How the ADA's multi-year engagement and task force shaped national nutrition guidance.

ADA News

April 07, 2026

Cancer Is Coming for Younger Adults — and the Field Isn’t Ready

The epidemiological tools built for midlife disease are straining to explain a generational shift

Conexiant

April 06, 2026

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Conexiant

April 06, 2026

UVB and Psoriasis: More Than Immunosuppression

UVB's benefits may run deeper than inflammation suppression—cholesterol metabolism could be a key link.

Conexiant

April 03, 2026

Was the GLP-1 Problem Always Cost?

A JAMA Viewpoint argues the BALANCE model targets the leading cause of discontinuation.

Conexiant

April 01, 2026

Prednisolone Linked to Metabolic Benefits

A randomized crossover trial found slower bone turnover and no safety differences compared with standard hydrocortisone regimens

Conexiant

March 30, 2026

GlycoRNA Comes into Focus with Mass Spectrometry Blueprint

New review maps analytical workflows to decode a surprising class of sugar-coated RNA

The Analytical Scientist

March 26, 2026

Obesity’s Cancer Role Underestimated

A proposed framework highlights potential sources of bias in current estimates

Conexiant

March 24, 2026

GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

Conexiant